Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 8
Submit an article Journal homepage
29
Views
4
CrossRef citations to date
0
Altmetric
Comment

Will quantitative flow ratio replace fractional flow reserve in the cathlab? Commentary to “validity and correlation of quantitative flow ratio with fractional flow reserve for assessment of intermediate coronary lesions.”

Walter DesmetUniversity Hospitals Leuven, Leuven, BelgiumCorrespondence[email protected]
Page 673 | Received 17 May 2022, Accepted 26 May 2022, Published online: 09 Jun 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Patrizio Lancellotti & Alain Nchimi. (2024) Bridging perspectives from prevention, diagnosis, management to economic aspects: the voice of Belgian cardiologists. Acta Cardiologica 79:1, pages 1-4.
Read now
Patrizio Lancellotti & Alain Nchimi. (2023) New approaches to cardiovascular diseases. Acta Cardiologica 78:9, pages 977-979.
Read now
Patrizio Lancellotti, Hélène Petitjean, Alain Nchimi & Bernard Cosyns. (2023) Special Issue on ischemic heart disease. Acta Cardiologica 78:1, pages 1-4.
Read now
Patrizio Lancellotti & Bernard Cosyns. (2022) Focus issue on diagnostic work-up and prognostic assessment in cardiac disease. Acta Cardiologica 77:8, pages 671-672.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.